Champions Oncology Inc Share Price Today: Live Updates & Key Insights

Champions Oncology Inc share price today is $5.97, up -5.48%. The stock opened at $6.15 against the previous close of $6.2, with an intraday high of $6.15 and low of $6.15.

Champions Oncology Inc Share Price Chart

Champions Oncology Inc

us-stock
To Invest in {{usstockname}}
us-stock

Champions Oncology Inc Share Price Performance

$5.97 -0.0548(-5.48%) CSBR at 23 Mar 2026 12:34 PM Biotechnology
Lowest Today 6.15
Highest Today 6.15
Today’s Open 6.15
Prev. Close 6.2
52 Week High 9.97
52 Week Low 5.50
Day’s Range: Low 6.15 High 6.15
52-Week Range: Low 5.50 High 9.97
1 day return -
1 Week return -0.83
1 month return +2.05
3 month return -14.87
6 month return -10.25
1 year return -39.22
3 year return +43.37
5 year return -49.87
10 year return -

Champions Oncology Inc Institutional Holdings

Battery Management Corp 17.44

NEA Management Company, LLC 12.34

Vanguard Group Inc 2.41

Tocqueville Asset Management L.P. 2.30

Vanguard Total Stock Mkt Idx Inv 1.66

Morgan Stanley - Brokerage Accounts 1.37

Renaissance Technologies Corp 1.12

BlackRock Inc 0.88

Mink Brook Asset Management LLC 0.58

Geode Capital Management, LLC 0.55

Vanguard Institutional Extnd Mkt Idx Tr 0.45

Northern Trust Corp 0.33

Acadian Asset Management LLC 0.26

HighTower Advisors, LLC 0.25

Fidelity Extended Market Index 0.23

Bank of New York Mellon Corp 0.19

State Street Corp 0.19

Dimensional Fund Advisors, Inc. 0.18

iShares Micro-Cap ETF 0.16

Bank of America Corp 0.16

GSA Capital Partners LLP 0.15

Essex Investment Management Company, LLC 0.13

O'Shaughnessy Asset Management LLC 0.09

Blackrock Extended Mkt Fund CF 0.09

CAMBRIDGE Invest RESEARCH ADVISORS, INC. 0.09

Fidelity Total Market Index 0.09

Extended Equity Market Fund K 0.08

Fidelity Nasdaq Composite Index 0.08

Fidelity Series Total Market Index 0.06

Spartan Extended Market Index Pool F 0.05

Schwab Total Stock Market Index 0.05

Northern Trust Extended Eq Market Idx 0.05

NT Ext Equity Mkt Idx Fd - L 0.05

Vanguard Instl Ttl Stk Mkt Idx InstlPls 0.05

NT Ext Equity Mkt Idx Fd - NL 0.04

Vanguard Instl Ttl Stck Mkt Idx Tr 0.04

Northern Small Cap Core I 0.04

Spartan Total Market Index Pool G 0.03

NT Ext Equity Mkt Idx Fd - DC - NL - T2 0.03

State St US Extended Mkt Indx NL Cl C 0.02

Champions Oncology Inc Market Status

Strong Buy: 1

Buy: 0

Hold: 0

Sell: 0

Strong Sell: 0

Champions Oncology Inc Fundamentals

Market Cap 81.38 M

PB Ratio 19.5511

PE Ratio 0.0

Enterprise Value 81.50 M

Total Assets 32.34 M

Volume 4267

Champions Oncology Inc Company Financials

Annual Revenue FY25:56944000 56.9M, FY24:50155000 50.2M, FY23:53870000 53.9M, FY22:49109000 49.1M, FY21:41040000 41.0M

Annual Profit FY25:26915000 26.9M, FY24:20754000 20.8M, FY23:24338000 24.3M, FY22:25477000 25.5M, FY21:19566000 19.6M

Annual Net worth FY25:4701000 4.7M, FY24:-7276000 -7.3M, FY23:-5335000 -5.3M, FY22:548000 0.5M, FY21:334000 0.3M

Quarterly Revenue Q1/2026:16559000 16.6M, Q4/2025:15035000 15.0M, Q3/2025:13995000 14.0M, Q2/2025:12355000 12.4M, Q1/2025:17039000 17.0M

Quarterly Profit Q1/2026:7384000 7.4M, Q4/2025:7416000 7.4M, Q3/2025:5642000 5.6M, Q2/2025:4690000 4.7M, Q1/2025:10024000 10.0M

Quarterly Net worth Q1/2026:-279000 -0.3M, Q4/2025:299000 0.3M, Q3/2025:-436000 -0.4M, Q2/2025:-1834000 -1.8M, Q1/2025:4495000 4.5M

About Champions Oncology Inc & investment objective

Company Information Champions Oncology, Inc., a technology-enabled research company, provides technology solutions for drug discovery and development in the United States. The company, through its Tumorgraft technology platform, provides personalized cancer care based upon the implantation of human tumors in immune-deficient mice. It also offers translational oncology solutions that utilizes its technology platform to provide research services that assist in the drug development process of pharmaceutical and biotechnology companies. In addition, the company offers Lumin Bioinformatics, an oncology data-driven software program which contains comprehensive information derived from research services and clinical studies. It markets its products through internet and sales force to pharmaceutical and biotechnology companies. The company was formerly known as Champions Biotechnology, Inc. and changed its name to Champions Oncology, Inc. in April 2011. Champions Oncology, Inc. was incorporated in 1985 and is headquartered in Hackensack, New Jersey.

Organisation Biotechnology

Employees 213

Industry Biotechnology

CEO Mr. Robert Brainin

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

Champions Oncology Inc FAQs

What is the share price of Champions Oncology Inc today?

The current share price of Champions Oncology Inc is $5.97.

Can I buy Champions Oncology Inc shares in India?

Yes, Indian investors can buy Champions Oncology Inc shares by opening an international trading and demat account with Motilal Oswal.

How to buy Champions Oncology Inc shares in India?

You can easily invest in Champions Oncology Inc shares from India by:

Can I buy fractional shares of Champions Oncology Inc?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of Champions Oncology Inc?

Champions Oncology Inc has a market cap of $81.38 M.

In which sector does Champions Oncology Inc belong?

Champions Oncology Inc operates in the Biotechnology sector.

What documents are required to invest in Champions Oncology Inc stocks?

To invest, you typically need:

What is the PE and PB ratio of Champions Oncology Inc?

The PE ratio of Champions Oncology Inc is N/A and the PB ratio is 19.55.